A 5-day-old preterm neonate (34 weeks gestation) born to an Rh-negative mother (unsensitized) presents with jaundice. Serum bilirubin is 14 mg/dL. Direct bilirubin is 0.8 mg/dL. Hemoglobin is 12 g/dL, reticulocyte count is 8%, and direct antiglobulin test (DAT/Coombs) is negative. What is the most appropriate next step in management?

Question

Accepted Answer

B. Check maternal blood type and antibody screen; start phototherapy based on preterm nomogram. ## Clinical Context

This is a **5-day-old preterm neonate (34 weeks)** with unconjugated hyperbilirubinemia. Key findings:
- **Negative DAT** → rules out hemolytic disease (ABO, Rh, other blood group incompatibilities)
- **Normal reticulocyte count (8%)** → no significant hemolysis
- **Normal hemoglobin** → no anemia
- **Low direct bilirubin (0.8 mg/dL)** → predominantly unconjugated (physiological/breastfeeding jaundice)

This is **NOT hemolytic disease of the newborn (HDN)** despite Rh-negative mother status (unsensitized = no prior sensitization, DAT negative = no active hemolysis).

## Key Point:
**Preterm infants have lower phototherapy thresholds** than term infants because of immature blood–brain barrier and increased risk of bilirubin encephalopathy. Always use the **preterm-specific nomogram**.

## Management Algorithm

```mermaid
flowchart TD
  A[Preterm neonate, Day 5, TSB 14 mg/dL, DAT negative]:::outcome --> B{Hemolysis present?}:::decision
  B -->|Yes: elevated reticulocyte, anemia, positive DAT| C[Investigate cause: ABO, Rh, G6PD, infection]:::action
  B -->|No: negative DAT, normal Hb, normal retic| D[Physiological/breastfeeding jaundice]:::outcome
  D --> E{Preterm or term?}:::decision
  E -->|Preterm| F[Use preterm phototherapy nomogram]:::action
  E -->|Term| G[Use term phototherapy nomogram]:::action
  F --> H[Plot TSB vs. age and gestational age]:::action
  G --> H
  H --> I{Above phototherapy threshold?}:::decision
  I -->|Yes| J[Start phototherapy]:::action
  I -->|No| K[Recheck TSB in 24 hours, optimize feeding]:::action
```

## High-Yield: Phototherapy Thresholds (Preterm vs. Term)

| Gestational Age | Day 5 TSB Threshold (mg/dL) |
|---|---|
| 35–37 weeks | ~13–14 |
| 38–42 weeks (term) | ~17.5–18 |

**At 34 weeks, day 5, TSB 14 mg/dL is AT or NEAR the phototherapy threshold.** The correct next step is to **apply the preterm nomogram** and decide on phototherapy based on that chart.

## Clinical Pearl:
**Why preterm infants have lower thresholds:**
1. Immature blood–brain barrier → bilirubin crosses more easily
2. Lower serum albumin and reduced bilirubin binding capacity
3. Increased risk of **acute bilirubin encephalopathy** and **chronic kernicterus**
4. Sepsis, acidosis, and hypoglycemia lower the safe threshold further

## Tip:
**Always check:**
1. **Maternal blood type and antibody screen** → rules out Rh/ABO/other incompatibility
2. **DAT (Coombs)** → rules out hemolytic disease
3. **Reticulocyte count and hemoglobin** → assesses for hemolysis
4. **Gestational age** → determines which phototherapy nomogram to use

In this case, negative DAT + normal reticulocyte + unsensitized Rh-negative mother = **no hemolytic disease**. The jaundice is physiological/nutritional. Management is phototherapy per **preterm nomogram**.

[cite:AAP Neonatal Jaundice Guidelines 2009; Cloherty & Stark Ch 18]

![Neonatal Jaundice diagram](https://mmcphlazjonnzmdysowq.supabase.co/storage/v1/object/public/blog-images/explanation/3739.webp)

Answer

A. Start phototherapy immediately; perform exchange transfusion if bilirubin rises above 18 mg/dL

Answer

C. Administer intravenous immunoglobulin (IVIG) and observe for hemolytic disease

Answer

D. Perform blood culture and start antibiotics for suspected sepsis-induced jaundice

Explanation

Clinical Context

Key Point:

Management Algorithm

High-Yield: Phototherapy Thresholds (Preterm vs. Term)

Clinical Pearl:

Tip:

Practice similar questions

Join our NEET PG community